title: [Immunoglobulin therapy for systemic lupus erythematosus].
abstract: A 25-year-old patient with lupus erythematosus was admitted with myositis and erythema of the skin under chloroquine therapy. After improvement of clinical symptoms with cyclophosphamide and prednisolone he was again progredient with myositis. The changing of therapy to methotrexate showed a hepatotoxic side effect with elevated liver enzymes. Under subsequent therapy with azathioprine and prednisolone he developed leukopenia and sepsis. Because of persistent erythema of the skin under therapy with different immunosuppressives we performed a therapy with high-dose intravenous immunoglobulins. After application of immunoglobulins we observed an improvement of the erythema after 10 days, which was persistent after dose reduction for about 4 months.
authors.affiliation: Medizinische Klinik, Universität Bonn.
authors.forename: N
authors.initials: N
authors.lastname: Utku
authors.forename: J
authors.initials: J
authors.lastname: von Kempis
authors.forename: J K
authors.initials: JK
authors.lastname: Rockstroh
authors.forename: T
authors.initials: T
authors.lastname: Sauerbruch
mesh_terms: D000328:Adult; D006801:Humans; D007116:Immunization, Passive / Q000379:methods*; D008180:Lupus Erythematosus, Systemic / Q000628:therapy*; D008297:Male
vernacular_title: Immunglobulintherapie bei systemischem Lupus erythematodes.